expenses For the year end of 2019, the management benefit was 14.38 million baht compare to 15.90 million baht, decrease by 1.52 million or 9.56% decreased because the company had adjust the organization to
15.90 million baht compare to 17.04 million baht, decrease by 1.14 million or 6.69% decreased because the company had adjust the organization to be more compact and more cost saving. 6. Financial cost For
benefit expenses For Quarter1 of the year 2019, the management benefit was 3.21 million baht compare to 4.35 million baht, decrease by 1.14 million or 26.21% decreased because the company had adjust the
had to be closed according to government policy. But the company was able to adjust to its profitable operating results this quarter details as follows: Management Discussion and Analysis Q2/2020 Page 3
Gross Profit Selling Admin Net(loss) profit Q1/17 212,140 78,137 19,861 24,659 21,584 Q1/18 213,552 76,707 21,974 18,709 27,898 % Change 0.67 (1.83) 10.64 (24.13) 29.25 In overall, the Company and its
date on January 1, 2020. By this summarization of business operation and financial statement of year 2019 was prepared under standard before the change and does not have retrospective improvements on
www.interpharma.co.th IP_OCS/011/2020 8th June 2020 Subject: Notify the Resolutions of the Board of Directors Meeting, Change of Objectives of Funds Usage, Acquisition of Assets, The Issuance of Debentures and Fix the
three years or upon occurrence of a widespread adverse incident; (2) To adjust the submission schedule for the Risk Level Assessment (RLA) report and IT audit report to be within the same period (during
liabilities stood at THB 7,174.9mn • Debt to Equity ratio stood at 1.04 times as of 31 December 2019, decreased from 1.14 times as at end of 2018 Change in accounting policies and reclassification in 2019
a fair price from the date of the change, the proportion of investment. By recognized profit on changes in the proportion of investment in the period of 9 months in year 2017 amount 6.84 million baht